Diclofenac Potassium Attenuates Dysmenorrhea and Restores Exercise Performance in Women With Primary Dysmenorrhea

被引:36
作者
Chantler, Ingrid [1 ]
Mitchell, Duncan [1 ]
Fuller, Andrea [1 ]
机构
[1] Univ Witwatersrand, Sch Physiol, Brain Funct Res Grp, ZA-2193 Johannesburg, South Africa
基金
新加坡国家研究基金会;
关键词
Menstrual pain; nonsteroidal anti-inflammatory drugs; physical performance; AEROBIC EXERCISE; MENSTRUAL-CYCLE; YOUNG-WOMEN; PAIN; PREVALENCE; INTENSITY; CONTRACEPTIVES; PERCEPTION; IMPACT;
D O I
10.1016/j.jpain.2008.08.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We assessed the efficacy of diclofenac potassium, a nonsteroidal anti-inflammatory drug, in alleviating menstrual pain and restoring exercise performance to that measured in the late-follicular phase of the menstrual cycle. Twelve healthy young women with a history of primary dysmenorrhea completed, in a random order, laboratory exercise-testing sessions when they were in the late-follicular (no menstruation, no pain) phase of the menstrual cycle and when they were experiencing dysmenorrhea and receiving, in a double-blinded fashion, either 100 mg of diclofenac potassium or placebo. We assessed the women's leg strength (1-repetition maximum test), aerobic capacity (treadmill walking test), and ability to perform a functional test (task-specific test). Compared with placebo, diclofenac potassium significantly decreased dysmenorrhea on the day of administration (Visual Analog Scale, P < .001 at all times). When receiving placebo for menstrual pain, the women's performance in the tests was decreased significantly, compared with when they were receiving diclofenac potassium for menstrual pain (P < .05) and compared with when they were in the late-follicular phase of the menstrual cycle (P < .05 for treadmill test, P < .01 for task-specific test and 1-repetition maximum test). Administration of diclofenac potassium for menstrual pain restored exercise performance to a level not different from that achieved in the late-follicular phase of the cycle. Perspective: In women with primary dysmenorrhea, menstrual pain, if untreated, decreases laboratory-assessed exercise performance. A recommended daily dose of a readily available nonsteroidal anti-inflammatory drug, diclofenac potassium, is effective in relieving menstrual pain and restoring physical performance to levels achieved when the women were in the late-follicular (no menstruation, no pain) phase of the menstrual cycle. (c) 2009 by the American Pain Society
引用
收藏
页码:191 / 200
页数:10
相关论文
共 38 条
[1]   AN EPIDEMIOLOGIC-STUDY OF YOUNG-WOMEN WITH DYSMENORRHEA [J].
ANDERSCH, B ;
MILSOM, I .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (06) :655-660
[2]  
Bale P, 1983, Br J Sports Med, V17, P46
[3]  
BALE P, 1985, AJSMS, V3, P19
[4]   Prevalence and impact of dysmenorrhea on Hispanic female adolescents [J].
Banikarim, C ;
Chacko, MR ;
Kelder, SH .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2000, 154 (12) :1226-1229
[5]   Concentrations of various arachidonic acid metabolites in menstrual fluid are associated with menstrual pain and are influenced by hormonal contraceptives [J].
Bieglmayer, C ;
Hofer, G ;
Kainz, C ;
Reinthaller, A ;
Kopp, B ;
Janisch, H .
GYNECOLOGICAL ENDOCRINOLOGY, 1995, 9 (04) :307-312
[6]  
BORG GAV, 1973, MED SCI SPORT EXER, V5, P90
[7]   Prevalence of Primary Dysmenorrhea in Canada [J].
Burnett, Margaret A. ;
Antao, Viola ;
Black, Amanda ;
Feldman, Kymm ;
Grenville, Andrew ;
Lea, Robert ;
Lefebvre, Guylaine ;
Pinsonneault, Odette ;
Robert, Magali .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2005, 27 (08) :765-770
[8]   The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain [J].
Chantler, Ingrid ;
Mitchell, Duncan ;
Fuller, Andrea .
CLINICAL JOURNAL OF PAIN, 2008, 24 (01) :39-44
[9]  
Coco AS, 1999, AM FAM PHYSICIAN, V60, P489
[10]   The visual analogue pain intensity scale: what is moderate pain in millimetres? [J].
Collins, SL ;
Moore, RA ;
McQuay, HJ .
PAIN, 1997, 72 (1-2) :95-97